Patients stay in control and connected
Eur J Neurosci 57(1):148162 Daniele G, Iozzo P, Molina-Carrion M et al (2015) Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system
Participants randomized to the 4 mg dose with a 2 mg starting dose had significantly fewer GI adverse events than those started directly at 4 mg
Retatrutide metabolic benefits Retatrutide has demonstrated even more dramatic metabolic benefits, particularly for liver health and insulin sensitivity
Juji A, Godina C, Belting M, Melander O, Juul Holst J, Ahlqvist E, et al
the information below is extrapolated from authorised GLP-1 and GLP-1/GIP receptor agonists (such as semaglutide and tirzepatide) and should be interpreted accordingly